Cargando…
B-cell Receptor Signaling Induced Metabolic Alterations in Chronic Lymphocytic Leukemia Can Be Partially Bypassed by TP53 Abnormalities
It has been unclear what role metabolism is playing in the pathophysiology of chronic lymphocytic leukemia (CLL). One reason is that the study of CLL metabolism is challenging due to the resting nature of circulating CLL cells. Also, it is not clear if any of the genomic aberrations observed in this...
Autores principales: | Kluckova, Katarina, Clear, Andrew J., D’Avola, Annalisa, Rassenti, Laura Z., Kipps, Thomas J., Gribben, John G., Riches, John C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208879/ https://www.ncbi.nlm.nih.gov/pubmed/35747847 http://dx.doi.org/10.1097/HS9.0000000000000722 |
Ejemplares similares
-
Advances in Understanding of Metabolism of B-Cell Lymphoma: Implications for Therapy
por: Kluckova, Katarina, et al.
Publicado: (2022) -
Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers
por: D’Avola, Annalisa, et al.
Publicado: (2023) -
PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma
por: D’Avola, Annalisa, et al.
Publicado: (2022) -
Lack of Allelic Exclusion in B Cell Chronic Lymphocytic Leukemia
por: Rassenti, Laura Z., et al.
Publicado: (1997) -
Telomere status in chronic lymphocytic leukemia with TP53 disruption
por: Guièze, Romain, et al.
Publicado: (2016)